Literature DB >> 28117537

Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?!

M Dirks1, H Pflugrad1, K Haag1, H L Tillmann2, H Wedemeyer3, D Arvanitis1, H Hecker4, A Tountopoulou1, A Goldbecker1, H Worthmann1, K Weissenborn1.   

Abstract

One of the most disabling symptoms of hepatitis C virus (HCV) infection is chronic fatigue. While this is accepted for HCV polymerase chain reaction (PCR)-positive patients, a relationship between HCV infection and chronic fatigue is questioned after successful virus eradication. As fatigue is a subjective criterion, we aimed to evaluate in addition mood alterations and cognitive function in HCV-exposed patients with only mild liver disease and to assess a) possible interrelationships between these factors and health-related quality of life and b) the impact of viremia and former interferon treatment. One hundred and fifty-nine anti-HCV-positive individuals without advanced liver disease answered health-related quality of life (HRQoL), fatigue and depression questionnaires and underwent a battery of attention and memory tests. Accompanying diseases which could distort the results of the study such as HIV co-infection or drug addiction were exclusion criteria. The patients were subdivided into four groups according to their viremia status and interferon treatment history. Patients' data were evaluated with respect to norms given in the respective test manuals and in addition compared to those of 33 age-matched healthy controls. Eighty-five per cent of the patients had chronic fatigue, 50-60% mild depression or anxiety, 45% memory deficits and 30% attention deficits, irrespective of their HCV viremia status or treatment history. HRQoL correlated negatively with chronic fatigue (P<.001), while cognitive deficits-especially memory function-were independent from fatigue and depression. HCV infection may cause long-standing cerebral dysfunction that significantly impairs HRQoL and may even persist after clearance of the virus.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  SF-36; chronic fatigue syndrome; cognitive dysfunction; health-related quality of live; hepatitis C

Mesh:

Substances:

Year:  2017        PMID: 28117537     DOI: 10.1111/jvh.12674

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

1.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

2.  Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV/HIV coinfected patients: effect on cognitive function, fatigue, and mental health.

Authors:  Felix Kleefeld; Sophie Heller; Patrick Ingiliz; Heiko Jessen; Anders Petersen; Ute Kopp; Antje Kraft; Katrin Hahn
Journal:  J Neurovirol       Date:  2018-05-21       Impact factor: 2.643

3.  Cerebral patterns of neuropsychological disturbances in hepatitis C patients.

Authors:  Tino Prell; Meike Dirks; Dimitrios Arvanitis; David Braun; Thomas Peschel; Hans Worthmann; Ramona Schuppner; Peter Raab; Julian Grosskreutz; Karin Weissenborn
Journal:  J Neurovirol       Date:  2019-01-04       Impact factor: 2.643

Review 4.  Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

Authors:  Sern Wei Yeoh; Alex C N Holmes; Michael M Saling; Ian P Everall; Amanda J Nicoll
Journal:  Hepatol Int       Date:  2018-06-21       Impact factor: 6.047

5.  Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.

Authors:  A A Shahin; H S Zayed; M Said; S A Amer
Journal:  Z Rheumatol       Date:  2018-09       Impact factor: 1.530

6.  Undetected psychiatric morbidity among HIV/AIDS patients attending Comprehensive Care Clinic (CCC) in Nairobi Kenya: towards an integrated mental health care.

Authors:  Pauline W Ng'ang'a; Muthoni Mathai; Anne Obondo; Teresia Mutavi; Manasi Kumar
Journal:  Ann Gen Psychiatry       Date:  2018-03-02       Impact factor: 3.455

7.  Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders.

Authors:  Nicolò de Gennaro; Lucia Diella; Laura Monno; Gioacchino Angarano; Michele Milella; Annalisa Saracino
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

8.  Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects.

Authors:  David Pires Barreira; Rui Tato Marinho; Manuel Bicho; Isabel Flores; Renata Fialho; Sílvia Ouakinin
Journal:  Front Psychol       Date:  2019-10-15

9.  Quality of Life and Work Ability among Healthcare Personnel with Chronic Viral Hepatitis. Evaluation of the Inpatient Rehabilitation Program of the Wartenberg Clinic.

Authors:  Claudia Westermann; Albert Nienhaus; András Treszl
Journal:  Int J Environ Res Public Health       Date:  2019-10-12       Impact factor: 3.390

10.  Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study.

Authors:  Gloria Vaghi; Benedetta Gori; Gionata Strigaro; Michela Burlone; Rosalba Minisini; Matteo N Barbaglia; Elena Brigatti; Claudia Varrasi; Mario Pirisi; Roberto Cantello
Journal:  J Neurovirol       Date:  2020-09-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.